HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SMTI
Sanara MedTech Inc.
SMTI lost money over the past year, so it has no meaningful PE right now.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SMTI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Under pressure |
SMTI's cash flow is currently healthy, and its revenue and profitability are stable, but its balance sheet is under pressure.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SMTI PE Valuation
SMTI has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SMTI Forward outlook
There aren't enough analyst estimates for SMTI to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over SMTI on earnings, with more consistent year-over-year improvement.
SMTI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.48 | +$3.74 |
| Q2 2026 | -$3.72 | -$2.56 |
| Q1 2026 | -$3.90 | -$2.56 |
| Q4 2025 | -$4.36 | -$3.22 |
| Q3 2025 | -$4.22 | -$3.23 |
| Q2 2025 | -$1.16 | -$0.38 |
| Q1 2025 | -$1.34 | -$0.75 |
| Q4 2024 | -$1.14 | -$0.62 |
SMTI lost $0.48 per share over the past year, a smaller loss than the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SMTI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
SMTI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28.4M | +8% |
| Q2 2026 | $28.1M | +8.9% |
| Q1 2026 | $27.8M | +19% |
| Q4 2025 | $27.5M | +4.7% |
| Q3 2025 | $26.3M | +22% |
| Q2 2025 | $25.8M | +28% |
| Q1 2025 | $23.4M | +26% |
| Q4 2024 | $26.3M | +49% |
SMTI's revenue has grown year over year every quarter since late 2020: $28M last quarter, up 8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -8.6 points |
| Q2 2026 | 6.3% | +6.5 points |
| Q1 2026 | 9.5% | +18 points |
| Q4 2025 | 3.8% | +5.2 points |
| Q3 2025 | 11% | +20 points |
| Q2 2025 | -0.1% | +14 points |
| Q1 2025 | -8.9% | -0.6 points |
| Q4 2024 | -1.4% | -0.1 points |
SMTI has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SMTI on cash flow, with more consistent year-over-year improvement.
SMTI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.9M | +250% |
| Q2 2026 | $2M | +125% |
| Q1 2026 | -$2.5M | +$1.2M |
| Q4 2025 | $3.9M | +349% |
| Q3 2025 | $1.1M | -45% |
| Q2 2025 | $902.7K | +$2.4M |
| Q1 2025 | -$3.7M | -$2.1M |
| Q4 2024 | $859.9K | +$1.8M |
SMTI's free cash flow has turned positive again: $7M over the past year, against −$842,048 the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SMTI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SMTI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.4% | +120K shares |
| 1 year | -1.8% | -158K shares |
| 3 years | +5.4% | +451K shares |
| 5 years | +17% | +1.3M shares |
| Available history | +41% | +2.6M shares |
SMTI has 9M diluted shares, down 1.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q4 2019 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SMTI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.4x | Elevated |
| Q2 2026 | 2.9x | Moderate |
| Q1 2026 | 3.4x | Elevated |
| Q4 2025 | 5.4x | High |
| Q3 2025 | 6.1x | High |
| Q2 2025 | 50.4x | High |
SMTI's net debt is about 3.4 years of its operating earnings (EBITDA), down from 6.1 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SMTI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.2 | Neutral |
| Stochastic | 55.3 | Neutral |
SMTI's weekly RSI is 59 (neutral) and its Stochastic is 55 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SMTI PE vs Healthcare Sector
SMTI has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SMTI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.5 | 2.8% below |
| 20 week MA | $32.2 | 1.2% above |
| 50 week MA | $25.5 | 28% above |
| 100 week MA | $28.0 | 16% above |
| 200 week MA | $32.0 | 1.8% above |
SMTI has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SMTI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.0 | $51.7 | +223% |
| 2021 | $51.7 | $25.7 | -50% |
| 2022 | $25.7 | $42.8 | +66% |
| 2023 | $42.8 | $41.1 | -4% |
| 2024 | $41.1 | $33.5 | -18% |
| 2025 | $33.5 | $24.2 | -28% |
| 2026 YTD | $24.2 | $32.5 | +34% |
SMTI has the edge over HIMS on returns for 2026, with the stronger performance.